netFormulary Berkshire West NHS NHS
Royal Berkshire Foundation Trust
Berkshire Healthcare NHS Foundation Trust
Newbury and District CCG
North and West Reading CCG
South Reading CCG
Wokingham CCG
 
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:
This formulary is used by multiple organisations. There may be some instances where an item is on the formulary for one organisation but not the others. To help distinguish between each organisation, text will be colour coded, i.e. information relating to the Royal Berkshire NHS Foundation Trust will be in blue and Berkshire Healthcare NHS Foundation Trust will be in purple. Please ensure you read all information detailed under a drug.  *** please note that the Royal Berkshire NHS Foundation Trust is available on the MicroGuide mobile app, which you can download from your app store***

Click Here for Link to MicroGuide via your web browser.

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (1,0)
Table 1. Summary of antibacterial therapy (0,0)
Table 2. Summary of antibacterial prophylaxis (0,0)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (3,1)
05.01.01.02 Penicillinase-resistant penicillins (2,1)
05.01.01.03 Broad-spectrum penicillins (4,5)
05.01.01.04 Antipseudomonal penicillins (1,1)
05.01.01.05 Mecillinams (0,2)
05.01.02 Cephalosporins, carbapenems and other beta-lactums (1,0)
Cephalosporins (8,7)
Other beta-lactam antibiotics (2,0)
05.01.02.01 Cephalosporins (0,0)
05.01.02.02 Carbapenems (2,0)
05.01.02.03 Other beta-lactums antibiotics (1,1)
05.01.03 Tetracyclines (5,8)
Tigecycline (0,1)
05.01.04 Aminoglycosides (5,5)
05.01.05 Macrolides (4,8)
05.01.06 Clindamycin (1,2)
05.01.07 Some other antibacterials (1,0)
Chloramphenicol (1,1)
Fusidic acid (1,1)
Vancomycin and teicoplanin (2,1)
Daptomycin (1,0)
Linezolid (2,0)
Quinupristin and dalfopristin (0,1)
Polymyxins (2,2)
05.01.08 Sulphonamides and trimethoprim (3,1)
05.01.09 Antituberculosis drugs (8,1)
05.01.10 Antileprotic drugs (1,2)
05.01.11 Metronidazole and tinidazole (1,4)
05.01.12 Quinolones (2,8)
05.01.13 Urinary-tract infections (3,4)
05.02 Antifungal drugs (7,4)
Treatment of fungal infections (0,0)
Drugs used in fungal infections (4,2)
05.02.01 Triazole antifungals (0,0)
05.02.02 Imidazole antifungals (0,0)
05.02.03 Polyene antifungals (0,0)
05.02.04 Echinocandin antifungals (1,2)
05.02.05 Other antifungals (0,1)
05.03 Antiviral drugs (0,0)
05.03.01 HIV infection (1,0)
Nucleoside reverse transcriptase inhibitors (15,2)
Protease inhibitors (7,3)
Non-nucleoside reverse transcriptase inhibitors (3,0)
Other antiretrovirals (4,1)
Pharmacokinetic enhancers of antiretrovirals (0,0)
05.03.02 Herpesvirus infections (0,0)
05.03.02.01 Herpes simplex and varicella-zoster infection (3,2)
05.03.02.02 Cytomegalovirus infrection (2,2)
05.03.03 Viral hepatitis (3,1)
05.03.03.01 Chronic hepatitis B (0,0)
05.03.03.02 Chronic hepatitis C (6,1)
05.03.04 Influenza (1,3)
05.03.05 Respiratory syncytial virus (2,3)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,0)
Treatment of malaria (0,0)
Falciparum malaria (treatment) (0,0)
Benign malarias (treatment) (0,0)
Prophylaxis against malaria (0,0)
Specific recommendations (0,0)
Artemether with lumefabtrine (0,1)
Chloroquine (1,4)
Mefloquine (0,1)
Primaquine (0,1)
Proguanil (0,4)
Pyrimethamine (1,2)
Quinine (1,1)
Tetracyclines (1,0)
05.04.02 Amoebicides (1,2)
05.04.03 Trichomonacides (0,0)
05.04.04 Antigiardial drugs (0,1)
05.04.05 Leishmaniacides (0,1)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (1,0)
05.04.08 Drugs for pneumocystis pneumonia (2,2)
Treatment (0,0)
Prophylaxis (0,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (1,4)
05.05.02 Ascaricides (0,0)
05.05.03 Drugs for tapeworm infections (0,1)
Taenicides (0,0)
Hydatid disease (0,0)
05.05.04 Drugs for hookworms (0,0)
05.05.05 Schistosomicides (0,1)
05.05.06 Filaricides (0,0)
05.05.07 Drugs for cutaneous larva migrans (0,1)
05.05.08 Drugs for strongyloidiasis (0,0)
netFormulary